Back to SafriCanna or All Bud/Flower

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This page was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Terpene Profile (Measured Values)

Total Terpene Content by Weight: 2.015% (~20.15mg/g)

Alpha-Pinene14.99%
(3.0mg/g)
Pine/Sharp156℃
Beta-Pinene7.3%
(1.5mg/g)
Pine/Herbal165℃
Limonene11.22%
(2.3mg/g)
Citrus/Sour177℃
Caryophyllene20.45%
(4.1mg/g)
Spice/Gas119℃
Linalool8.39%
(1.7mg/g)
Floral/Lavender198℃
Humulene12.75%
(2.6mg/g)
Earthy/Spice107℃
Ocimene3.57%
(0.7mg/g)
Herbal/Sweet174-175℃
Carene21.34%
(4.3mg/g)
Earthy/Sweet168℃

MedBud currently tracks 39 common terpenes.

Dosing Look-Up Table (Estimated)

0.01/g2.2/mg THCTrace CBD
0.05/g11/mg THCTrace CBD
0.1/g22/mg THCTrace CBD
0.15/g33/mg THCTrace CBD
0.2/g44/mg THCTrace CBD
0.25/g55/mg THCTrace CBD
0.3/g66/mg THCTrace CBD
/gCalculate THCCalculate CBD

Please note values above are based on registered THC/CBD percentages, subject to ±10% allowed variance. Values provided are 'best case', losses to air during vaporisation or combustion will always occur.

Medication Details

Brand
South Africa SafriCanna
Designation
BLU T22
Cultivar/Strain
Blunicorn
Classification
Hybrid
Chemotype
Type I: High THC
Flower Provided
Trimmed Whole Flower
THC Potential Range (±10%)
19.8-24.2%
CBD Potential Range (±10%)
<1%
Cultivated/Produced by
South Africa SafriCanna
Cultivated in
Flag of South Africa South Africa
Irradiation
Gamma-Irradiated
Imported by
United Kingdom Grow Group UK
Imported as
Schedule I: Raw Material
Packaged in
Flag of United Kingdom United Kingdom
Packaged by
United Kingdom IPS Pharma

Patient Repackaging Label (BETA)

Label for Repackaging Download Thermal Label
Size: 76mm x 38mm (or other 2:1 format label)

It is generally recommended to keep medication in original packaging, lawful possession of medication in other packaging will face increased scrutiny.

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: Available

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Main Partner Pharmacy

Pharmacy Distributor

  • Grow Group UK

Dispensing Patient Pharmacies

  •  Logo

Further details to follow.

Information provided could come from a third-party source, and may not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).

South Africa About SafriCanna Pty Ltd.

SafriCanna Logo

SafriCanna is pioneering the shift towards a future where South African medicinal cannabis is recognised in every corner of the globe.

SafriCanna is pioneering the shift towards a future where South African Medicinal Cannabis is recognised in every corner of the globe.

Our primary mandate is to develop a full suite of medicinal EU-GMP cannabis products with our aim being to distribute to the ever-growing international cannabis market.

The overseas medicinal cannabis marketplace serves as a perfect point of departure for SafriCanna due to the fact that the market is developed and going from strength-to-strength.

South Africa is home to some of the finest cannabis in the world. Our climate and growing methods enable us to produce products that could compete in any marketplace worldwide. Infiltrating the international cannabis landscape forms part of a bigger strategy that will then see SafriCanna diversifying its offering and catering to a broader consumer base.

South Africa is a predominantly untapped resource in the global Medicinal Cannabis market, and as our continent plays catch-up, not only on legalisation, but also on growth and distribution, SafriCanna aims to assert itself as South Africa’s premium, fully-integrated Medicinal Cannabis brand. The face of cannabis is changing, and as it continues to do so, the opportunity for SafriCanna to develop a premium, intrinsically South African offering is becoming more and more prevalent.

SafriCanna is pioneering the shift towards a future where South African medicinal cannabis is recognised in every corner of the globe.

safricanna.com

  Information provided is partially community sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)